Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV Study to Investigate the Safety and Efficacy of Regorafenib in Indian Patients With Metastatic Colorectal Cancer (mCRC).

NCT03564938 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT03564938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03564938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV Study to Investigate the Safety and Efficacy of Regorafenib in Indian Patients With Metastatic Colorectal Cancer (mCRC).
Lead sponsor
Bayer
Phase
Phase 4
Overall status
Completed
Start date
July 30, 2018
Completion date
December 1, 2023
Enrollment
100 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer